A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19
Hope Biosciences is conducting a research study of an investigational product called allogeneic adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as treatment for patients suspected to have COVID-19. The study purpose is to evaluate the safety and efficacy of four IV infusions of either placebo or HB-adMSCs in subjects with COVID-19.
100 Clinical Results associated with River Oaks Hospital & Clinics LLC
0 Patents (Medical) associated with River Oaks Hospital & Clinics LLC
100 Deals associated with River Oaks Hospital & Clinics LLC
100 Translational Medicine associated with River Oaks Hospital & Clinics LLC